Related Experiment Videos
The epidemic of AIDS virus infection, what is the interest for oncologists?
1Division of Infectious Diseases, St Pierre University Hospital, Brussels, Belgium.
European Journal of Cancer & Clinical Oncology
|February 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff.
The Journal of hospital infection·2020
Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2018
[Professional fatigue syndrome (burnout) : Part 2 : from therapeutic management].
Revue medicale de Liege·2017
[Professional fatigue syndrome (burnout). Part 1 : identification by the general practitioner].
Revue medicale de Liege·2017
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015
The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.
European journal of cancer & clinical oncology·1989
Nutritional factors and cancers of the breast, endometrium and ovary.
European journal of cancer & clinical oncology·1989
Reproductive factors and cancers of the breast, ovary and endometrium.
European journal of cancer & clinical oncology·1989
Multiple primary cancers of the breast, endometrium and ovary.
European journal of cancer & clinical oncology·1989
Cancers of the breast, endometrium and ovary: geographic correlations.
European journal of cancer & clinical oncology·1989
Hormone replacement therapy in women treated for breast cancer.
European journal of cancer & clinical oncology·1989
Calreticulin and myeloproliferative neoplasms: linking biology to targeted therapies.
Expert review of clinical immunology·2026
MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
TRPM4 promotes ErSO-mediated oncosis-like cell death in prostate cancer cells.
Cancer research communications·2026
NEK2 Promotes OSCC Invasion and Metastasis by Activating TNF-α Signaling Through Impairment of Desmosomal Adhesion.
BioFactors (Oxford, England)·2026
Epigenetic modulation of NKG2D ligands enhances NKG2D-CAR T cell efficacy in neuroblastoma.
Journal of translational medicine·2026